GlassScriptPhysician profile
Robin Marie Moherek
NPI 1386724524
$589.12
in general payments reported to CMS, 2019-2025
15 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.46 · 2020: $40.04 · 2021: $33.06 · 2022: $82.40 · 2023: $115 · 2024: $137 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $105.43 | 2019-2023 | |
| Astellas Pharma US INC | $95.06 | 2024-2025 | Veozah |
| Abbvie INC. | $65.95 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $59.73 | 2022-2025 | |
| Organon LLC | $53.98 | 2025 | Nexplanon |
| Sage Therapeutics, LLC | $41.26 | 2024 | |
| Shield Therapeutics INC | $36.22 | 2023 | Accrufer |
| Sumitomo Pharma America, INC. | $28.51 | 2024 | Myfembree |
| Exact Sciences Corporation | $21.57 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $15.66 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.44 | 2019 | |
| Millicent US INC | $13.88 | 2025 | Femlyv |
| Exeltis, USA INC. | $13.56 | 2020 | |
| Meditrina | $12.41 | 2024 | |
| Therapeuticsmd, INC. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Moherek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.